← Leaderboards
Meifeng Xu
University Of Cincinnati
$4,938,461
Attributed
$8,671,386
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $931.4K · FY2006–21$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$8,671,386 · 4
By mechanism
R01$8,671,386 · 4
Top collaborators
- Muhammad Ashraf10 shared
- W Keith Jones5 shared
- Min Liu5 shared
Others in their field
Top investigators on “Mesenchymal Stem Cells”
- Ralph Parchment · Leidos Biomedical Research, Inc.$30,925,921
- Joshua M Hare · Johns Hopkins University$24,486,057
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Darwin Johnson Prockop · Thomas Jefferson University$20,016,289
- Bing Ren · Ludwig Institute For Cancer Research$17,040,291
- Richard E. Champlin · University Of Texas Md Anderson Can Ctr$16,195,855
Research focus
Mesenchymal Stem CellsStem CellsCardiacRepairedMyocardial IschemiaNatural RegenerationCellsMyocardiumIn VivoMyocardial InfarctionMyocardialBaseMediatingHeartCell TherapyCardiac MyocytesBone MarrowMolecularEnvironmentEngineeringParacrineIschemiaAngiogenesisInfarction
Grant awards (20)
Smarter exosomes derived from engineered MSCs promote neo-vascularization$505,044
R01 · FY2021 · HL · contact PI
Smarter exosomes derived from engineered MSCs promote neo-vascularization$505,044
R01 · FY2020 · HL · contact PI
The therapeutic potential of smarter exosomes derived from engineered MSCs on Alzheimer's disease$401,250
R01 · FY2020 · HL · contact PI
Smarter exosomes derived from engineered MSCs promote neo-vascularization$504,388
R01 · FY2019 · HL · contact PI
Smarter exosomes derived from engineered MSCs promote neo-vascularization$502,815
R01 · FY2018 · HL · contact PI
MicroRNA as mediators of angiogenesis & ischemic myocardial repair$498,846
R01 · FY2016 · HL · contact PI
MicroRNA as mediators of angiogenesis & ischemic myocardial repair$491,362
R01 · FY2015 · HL · contact PI
MicroRNA as mediators of angiogenesis & ischemic myocardial repair$488,868
R01 · FY2014 · HL · contact PI
Wnt11 signaling in stem cell survival and cardiac regeneration$380,804
R01 · FY2014 · HL · contact PI
MicroRNA as mediators of angiogenesis & ischemic myocardial repair$474,901
R01 · FY2013 · HL · contact PI
Wnt11 signaling in stem cell survival and cardiac regeneration$369,923
R01 · FY2013 · HL · contact PI
MicroRNA as mediators of angiogenesis & ischemic myocardial repair$542,796
R01 · FY2012 · HL · contact PI
Wnt11 signaling in stem cell survival and cardiac regeneration$388,575
R01 · FY2012 · HL · contact PI
Wnt11 signaling in stem cell survival and cardiac regeneration$392,500
R01 · FY2011 · HL · contact PI
Wnt11 signaling in stem cell survival and cardiac regeneration$381,100
R01 · FY2010 · HL · contact PI
Mobilized Stem Cells in Cardiomyogenesis & Angiogenesis$372,621
R01 · FY2010 · HL · contact PI
Mobilized Stem Cells in Cardiomyogenesis & Angiogenesis$372,621
R01 · FY2009 · HL · contact PI
Mobilized Stem Cells in Cardiomyogenesis & Angiogenesis$372,621
R01 · FY2008 · HL · contact PI
Mobilized Stem Cells in Cardiomyogenesis & Angiogenesis$360,467
R01 · FY2007 · HL · contact PI
Mobilized Stem Cells in Cardiomyogenesis & Angiogenesis$364,840
R01 · FY2006 · HL · contact PI